NEW YORK, June 21, 2017 /PRNewswire/ --
If you want a stock review on IDXG, G, TRU, or VNTV then come over to http://dailystocktracker.com/register/and sign up for your free customized reports today. The Business Services space accounts for an ever-growing portion of a country's gross domestic product, as the economy shifts over time from agriculture to industry and even business services. Therefore,
Shares in Parsippany, New Jersey headquartered Interpace Diagnostics Group Inc. saw a drop of 3.35%, ending Tuesday's trading session at $0.87. The stock recorded a trading volume of 1.08 million shares. The Company's shares are trading 59.13% below their 50-day moving average. Moreover, shares of Interpace Diagnostics, which develops and commercializes molecular diagnostic tests to detect genetic and other molecular alterations associated with gastrointestinal and endocrine cancers, have a Relative Strength Index (RSI) of 20.98.
On June 05th, 2017, Interpace Diagnostics announced that it has entered into a Laboratory Services Agreement with Einstein Medical Center of Philadelphia (Einstein) to provide expanded laboratory analytical services to the latter for improved identification of indeterminate thyroid nodules, through the Company's combined ThyGenX® and ThyraMIR® molecular tests. The new agreement makes Interpace products available to Einstein physicians who wish to use the products for patients with suspected thyroid cancer. Visit us today and access your complete report on IDXG for free at:
Hamilton, Bermuda-based Genpact Ltd's stock closed the day flat at $27.25 with a total trading volume of 839,021 shares. The Company's shares have advanced 2.79% in the past month, 12.79% in the previous three months, and 11.96% since the start of this year. The stock is trading 5.60% and 11.41% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Genpact, which provides business process outsourcing and information technology (IT) management services worldwide, have an RSI of 60.72.
On June 01st, 2017, Genpact announced that its Board of Directors has declared a cash dividend of $0.06 per common share for Q2 2017. The dividend is payable on or about June 28th, 2017, to shareholders of record as of the close of business on June 12th, 2017. The declaration of any future dividends is subject to the discretion of the Company's Board of Directors. The complimentary research report on G can be accessed at:
On Tuesday, shares in Chicago, Illinois headquartered TransUnion recorded a trading volume of 910,413 shares. The stock ended the day 0.61% lower at $44.03. The Company's shares have advanced 5.08% in the past month, 17.82% in the previous three months, and 42.35% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 6.72% and 24.46%, respectively. Furthermore, shares of TransUnion, which provides risk and information solutions, have an RSI of 64.31.
On June 12th, 2017, TransUnion announced that Suzanne P. Clark and Thomas L. Monahan have been appointed to its Board of Directors. Clark, 49, is currently Senior Executive Vice President of the US Chamber of Commerce. Monahan, 50, was Chairman and CEO of CEB, Inc. Register for free on DailyStockTracker.com and download the research report on TRU at:
Cincinnati, Ohio headquartered Vantiv Inc.'s stock dropped 1.05%, finishing yesterday's session at $60.50. A total volume of 2.29 million shares was traded, which was above their three months average volume of 1.35 million shares. The Company's shares have advanced 1.48% on an YTD basis. The stock is trading below its 200-day moving average by 0.24%. Additionally, shares of Vantiv, which through its subsidiary, Vantiv Holding, LLC, provides electronic payment processing services to merchants and financial institutions in the US, have an RSI of 38.27.
On June 12th, 2017, research firm Pacific Crest downgraded the Company's stock rating from 'Overweight' to 'Sector Weight'.
On June 15th, 2017, Vantiv announced that the Company was selected winner of the 2017 NAFCU Innovation Award for its fraud protection solution, OmniShield. The award, which was announced on June 14th, 2017 during NAFCU's annual conference and solutions expo in Honolulu, comes on the heels of recent internal analysis of MasterCard data by the Company that showed Gross Fraud Basis Points for its issuers were 32% lower than the industry average. Visit us now and access your full report on VNTV for free at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: firstname.lastname@example.org Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All